|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Long-lived and other asset impairment | |||||
| Non-cash restructuring charges | |||||
| Equity in net loss of unconsolidated affiliate | |||||
| Unrealized change in fair value of investment in unconsolidated affiliate | |||||
| Inventory write-downs | |||||
| Amortization of operating lease right-of-use assets | |||||
| Amortization of deferred financing costs | |||||
| Amortization of debt premium | |||||
| Amortization of capitalized implementation costs | |||||
| Debt extinguishment loss | |||||
| Stock-based compensation expense | |||||
| Provision for credit losses | |||||
| Gain on sale of assets, net | |||||
| Deferred income tax provision | |||||
| Amortization of contract costs | |||||
| Deferred revenue recognized in earnings | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Other assets | |||||
| Contract costs | |||||
| Accounts payable and other liabilities | |||||
| Deferred revenue | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale of business | |||||
| Proceeds from sale of property, equipment and other assets | |||||
| Proceeds from insurance and other settlements | |||||
| Cash paid in Acquisition, net of cash acquired | |||||
| Investments in unconsolidated affiliates | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Borrowings of long-term debt | |||||
| Repayments of long-term debt | |||||
| Redemption and partial repayment of 2027 Notes | |||||
| Proceeds from 2032 Notes offering | |||||
| Payments of debt issuance costs | |||||
| Dividends paid to stockholders | |||||
| Repurchases of common stock | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Net proceeds from issuance of common stock | |||||
| Proceeds from stock issued under ESPP | |||||
| Contribution to Enerflex | |||||
| Net cash (used in) provided by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid, net | |||||
| Supplemental disclosure of non-cash investing transactions: | |||||
| Accrued capital expenditures | |||||
| Issuance of Archrock common stock pursuant to Acquisition | |||||
| TOPS | |||||
| NGCS | |||||
| Total issuance of Archrock common stock pursuant to Acquisition | |||||
Loading...